These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2629366)

  • 1. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
    Assmann I; Kassel P; von Knorre G
    Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
    Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the effects of ethacizine and Bonnecor in the treatment of supraventricular paroxysmal tachycardia].
    Lukoshiavichiute AI; Gedrimene DA; Fol'kman G
    Kardiologiia; 1991 Jan; 31(1):67-70. PubMed ID: 2046254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of body position on the ability to initiate paroxysmal supraventricular reentry tachycardias and on the conduction system properties of the reentry circuit].
    Dannberg G; Volkmann H; Kühnert H
    Z Gesamte Inn Med; 1987 Jun; 42(11):289-94. PubMed ID: 3660882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic electrical procedures in recurring, drug refractory tachycardias. I. Antitachycardiac implantable pacemaker systems].
    Volkmann H; Paliege R; Kühnert H; Lungershausen W; Rupprecht J
    Z Gesamte Inn Med; 1986 Dec; 41(24):676-82. PubMed ID: 3564591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The usefulness of adenosine triphosphate in supraventricular paroxysmal tachycardias].
    Jornet A; Palet J; Usón M; Petit M
    Rev Clin Esp; 1993 Feb; 192(2):70-2. PubMed ID: 8460236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
    O'Brien JF; Tremml GP; Falk JL
    Am J Emerg Med; 1996 Jan; 14(1):50-2. PubMed ID: 8630157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
    G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
    Drescher S; Bosch RF; Mewis C; Kühlkamp V
    Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitachycardia pacing therapy in supraventricular tachycardia using the microcomputer-guided Tachylog 651 pacemaker].
    Gerckens U; Manz M; Kirchhoff PG; Lüderitz B
    Z Kardiol; 1986 Aug; 75(8):473-9. PubMed ID: 3776286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
    Pintér A; Zámolyi K; Székely A; Préda I
    Orv Hetil; 1994 Jul; 135(28):1535-8. PubMed ID: 8058296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
    Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.